Karen Prange

Affiliations

  • Director at Atricure Inc. (ATRC), 2025-05-21
  • at Nevro Corp (NVRO), 2025-04-03
  • Director at Embecta Corp. (EMBC), 2025-02-14
  • Director at Viewray Inc. (VRAY), 2023-07-21
  • Director at Cantel Medical Corp (CMD), 2021-06-02
  • Evp&Ceo Gl.ah.med.den.sur.grp at Henry Schein Inc (HSIC), 2018-03-06
  • Svp&Pres, Uro & Pelvic Health at Boston Scientific Corp (BSX), 2016-03-08
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
VRAY $2.66 26,300 $69,958.00 83,754 2022-05-10 Filing
VRAY $2.66 10,000 $26,592.00 57,454 2022-05-10 Filing
VRAY $2.66 1,300 $3,451.50 47,454 2022-05-10 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ATRC $38.12 6,100 $232,532.00 17,828 2025-03-05 Filing
VRAY $0.05 37,600 $1,917.60 8,799 2023-07-21 Filing
VRAY $0.08 91,866 $6,889.95 46,399 2023-07-19 Filing
ATRC $47.89 713 $34,145.57 16,140 2023-06-08 Filing
BSX $17.27 14,747 $254,748.53 38,395 2016-03-08 Filing